Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1954
HER2amp
Basal A
GSK1838705A
IGF1R
RTK
7455.098
uM
4.69590
4.83720
-0.0544 -0.0571 3.6461 0.2782
0.9262
1.3433
HCC1954
HER2amp
Basal A
GSK1838705A
IGF1R
RTK
7454.098
uM
11.22020
18.91190
-0.8748 -1.0000 2.1043 0.2733
0.9660
1.2964
HCC1954
HER2amp
Basal A
GSK1838705A
IGF1R
RTK
7457.098
uM
12.50550
23.65110
-0.7200 -1.0000 1.7240 0.2032
0.9911
1.8323
HCC1954
HER2amp
Basal A
GSK1838705A
IGF1R
RTK
7455.092
uM
32.97390
41.07660
-0.8400 -1.0000 5.0000 0.0859
0.9941
1.6605
HCC1954
HER2amp
Basal A
GSK1838705A
IGF1R
RTK
7456.091
uM
6.77990
8.30110
-0.8487 -0.8502 4.9076 0.3833
0.9974
1.7629
HCC1954
HER2amp
Basal A
GSK1838705A
IGF1R
RTK
7457.07
uM
7.230
13.91740
-0.7848 -0.9295 1.6040 0.2631
0.9975
1.5631
HCC1954
HER2amp
Basal A
GSK461364
PLK1
PLK
7839.001
uM
0.00067
0.00070
-0.4867 -0.1112 5.0000 0.8932
0.8549
1.8919
HCC1954
HER2amp
Basal A
GSK461364
PLK1
PLK
9386.001
uM
0.00862
0.01038
-0.6745 -0.4278 3.3304 0.8885
0.9609
1.3243
HCC1954
HER2amp
Basal A
GSK461364
PLK1
PLK
7837.001
uM
0.00799
0.00895
-0.4876 -0.3851 5.0000 0.8912
0.9776
1.5358
HCC1954
HER2amp
Basal A
GSK923295
CENPE
Kinesin
7839.001
uM
0.02230
0.02766
-0.5742 -0.3190 2.2929 0.7255
0.9629
1.8919
HCC1954
HER2amp
Basal A
GSK923295
CENPE
Kinesin
9386.001
uM
0.02279
0.02968
-0.7003 -0.5767 2.9028 0.8609
0.9930
1.3243
HCC1954
HER2amp
Basal A
GSK923295
CENPE
Kinesin
7837.001
uM
0.01816
0.02515
-0.6911 -0.5667 2.3282 0.8517
0.9943
1.5358
HCC1954
HER2amp
Basal A
Ibandronate
FDPS
11055.143
uM
58.56780
59.77120
-0.0661 -0.0398 3.7613 0.2374
0.9954
1.7215
HCC1954
HER2amp
Basal A
ICRF-193
TOP2
TOP
11055.151
uM
48.44540
999.70680
0.4720 -0.4729 0.2199 0.1876
0.8897
1.8913
HCC1954
HER2amp
Basal A
IKK16
IKK
NFKB
7454.093
uM
1.95380
3.5180
-0.9269 -0.9969 1.8644 0.5728
0.9463
1.3347
HCC1954
HER2amp
Basal A
IKK16
IKK
NFKB
7455.093
uM
1.59460
2.6590
-0.8567 -0.8897 1.9992 0.4552
0.9973
1.7255
HCC1954
HER2amp
Basal A
IKK16
IKK
NFKB
10469.1
uM
2.06480
3.12650
-0.9054 -0.9276 2.5287 0.4622
0.9989
1.5717
HCC1954
HER2amp
Basal A
Imatinib
ABL/KIT/PDGFR
nRTK
7454.092
uM
7.75220
18.65990
-0.9487 -1.0000 1.2507 0.6053
0.9808
1.2402
HCC1954
HER2amp
Basal A
Imatinib
ABL/KIT/PDGFR
nRTK
7456.091
uM
5.13170
10.86530
-0.8855 -0.9006 1.3731 0.5955
0.9967
1.7629
HCC1954
HER2amp
Basal A
Imatinib
ABL/KIT/PDGFR
nRTK
7455.092
uM
13.0090
19.65330
-0.8605 -0.8359 2.3818 0.4627
0.9983
1.6605
HCC1954
HER2amp
Basal A
Imatinib
ABL/KIT/PDGFR
nRTK
7457.09
uM
10.43810
16.94650
-0.8714 -0.8872 2.1057 0.5127
0.9987
1.7392
HCC1954
HER2amp
Basal A
Ispinesib
KSP
Kinesin
7457.067
uM
0.02045
0.02659
-0.9101 -0.6758 3.2605 0.9330
0.9852
1.8574
HCC1954
HER2amp
Basal A
Ispinesib
KSP
Kinesin
7456.067
uM
0.02697
0.03224
-0.8657 -0.7198 5.0000 0.9493
0.9949
1.8797
HCC1954
HER2amp
Basal A
Ixabepilone
TUBB
TUBB
7457.094
uM
0.00051
0.00078
-0.8956 -0.6816 2.0313 1.5901
0.9463
1.8462
HCC1954
HER2amp
Basal A
Ixabepilone
TUBB
TUBB
7455.095
uM
0.00203
0.00339
-0.9014 -0.6099 1.5659 1.1517
0.9624
1.8461